Efficacy of OnabotulinumtoxinA in Improving Oral Aperture in Patients With Scleroderma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
OnabotulinumtoxinA improves oral aperture in patients with scleroderma: A small clinical trial
J Am Acad Dermatol 2023 Jun 08;[EPub Ahead of Print], CD Gonzalez, JJ Pamatmat, KM Burningham, M Yang, HW GoffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.